Fulya Doganer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fulya Doganer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ahu Soyocak
Faculty of Medicine, Department of Medical Biology, Istanbul Aydın University, Istanbul, Türkiye
3 shared publications - Didem Turgut Coşan
Eskisehir Osmangazi University, Institute of Science, Department of Biolotechnology, and Biosafety, Eskisehir, Turkiye
3 shared publications - Merih Özgen
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
3 shared publications - Fezan Mutlu
Eskişehir Osmangazi Üniversitesi
2 shared publications - Hasan Veysi Güneş
Eskisehir Osmangazi University
2 shared publications - İrfan Değirmenci
Department of Medical Biology, Faculty of Medicine, Kutahya Health Sciences University
2 shared publications
Latest Publications
- Open Access
- 3 February 2025
- Published by Springer Nature in Plasmonics
- p. 1-19
Synthesis of a Novel Supermagnetic Fe3O4 Nanoparticles and their Congo Red Dye Removal, Cytotoxic, Antioxidant, and Antimicrobial Activities
Plantago lanceolata is a traditional medicinal plant that has attracted significant interest from researchers due to the use of its physiologically active components, particularly polyphenolics (flavonoids, hydroxycinnamic acids), in various fields. The aim of this study is to synthesize iron oxide (PLE@FeNPs) nanoparticles using a green synthesis approach with Plantago lanceolata (P. lanceolata) leaf extracts, characterize them, evaluate their in vitro effects, and assess their use in the removal of Congo red (CR) from wastewater. We carried out the physicochemical characterization of the nanoparticles using UV–Vis, FT-IR, and XRD spectroscopies; TEM and SEM microscopy; and Zetasizer particle size analysis. While the distinct peaks in XRD confirm the crystalline structure, TEM has determined an average particle size (8 nm) for PLE@NPs with deformed spherical nanoparticles. The FT-IR spectra showed that bioactive compounds from P. lanceolata were involved in the participation of PLE@FeNPs. EDX confirmed the presence of iron in the designed PLE@FeNPs. The antibacterial, antioxidant, and anticancer analyses of the studied PLE@FeNPs revealed significant activities. We investigated the adsorption kinetics of CR on PLE@FeNPs, taking into account initial dye concentration, different pH levels, adsorbent dosages, and temperature. At optimal conditions (concentration, 50 ppm; dosage, 15 mg; pH, 8), the degradation of CR dye in sunlight was found to be 99%. The small size of PLE@NPs (8 nm) and the more negative zeta potential (− 12.2 mV) support this situation. The equilibrium data demonstrated a good fit to the Langmuir isotherm model, outperforming the Freundlich isotherm model. The results showed that the pseudo-second-order kinetic model accurately described the kinetic data. PLE@NPs exhibited significant antioxidant, antimicrobial, and anticancer activities. This situation suggests that the nanocomposition of PLE@NPs obtained through the green route may have improved efficiency due to various synergistic effects. Overall, these results pave the way for further applications in dye removal and biological applications of environmentally friendly PLE@FeNPs. Graphical Abstract
- 3 February 2025
- Published by Springer Nature in Plasmonics
- p. 1-19
Open AccessSynthesis of a Novel Supermagnetic Fe3O4 Nanoparticles and their Congo Red Dye Removal, Cytotoxic, Antioxidant, and Antimicrobial Activities
Plantago lanceolata is a traditional medicinal plant that has attracted significant interest from researchers due to the use of its physiologically active components, particularly polyphenolics (flavonoids, hydroxycinnamic acids), in various fields. The aim of this study is to synthesize iron oxide (PLE@FeNPs) nanoparticles using a green synthesis approach with Plantago lanceolata (P. lanceolata) leaf extracts, characterize them, evaluate their in vitro effects, and assess their use in the removal of Congo red (CR) from wastewater. We carried out the physicochemical characterization of the nanoparticles using UV–Vis, FT-IR, and XRD spectroscopies; TEM and SEM microscopy; and Zetasizer particle size analysis. While the distinct peaks in XRD confirm the crystalline structure, TEM has determined an average particle size (8 nm) for PLE@NPs with deformed spherical nanoparticles. The FT-IR spectra showed that bioactive compounds from P. lanceolata were involved in the participation of PLE@FeNPs. EDX confirmed the presence of iron in the designed PLE@FeNPs. The antibacterial, antioxidant, and anticancer analyses of the studied PLE@FeNPs revealed significant activities. We investigated the adsorption kinetics of CR on PLE@FeNPs, taking into account initial dye concentration, different pH levels, adsorbent dosages, and temperature. At optimal conditions (concentration, 50 ppm; dosage, 15 mg; pH, 8), the degradation of CR dye in sunlight was found to be 99%. The small size of PLE@NPs (8 nm) and the more negative zeta potential (− 12.2 mV) support this situation. The equilibrium data demonstrated a good fit to the Langmuir isotherm model, outperforming the Freundlich isotherm model. The results showed that the pseudo-second-order kinetic model accurately described the kinetic data. PLE@NPs exhibited significant antioxidant, antimicrobial, and anticancer activities. This situation suggests that the nanocomposition of PLE@NPs obtained through the green route may have improved efficiency due to various synergistic effects. Overall, these results pave the way for further applications in dye removal and biological applications of environmentally friendly PLE@FeNPs. Graphical Abstract
- 1 November 2024
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 44 (10) , 783-792
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Turkish postmenopausal women with osteoporosis
Osteoporosis is a common age-related skeletal disease, characterized by changes in the microarchitectural structure of bone tissue and decreased bone mass, especially affecting postmenopausal women. Genetic and environmental factors affecting bone metabolism play a role in the development of osteoporosis. Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in the conversion of homocysteine to methionine. Genetic variations in the MTHFR gene lead to impaired function or inactivation of this enzyme. A decrease in MTHFR enzyme activity and an increase in homocysteine levels affect bone metabolism. In this study, we aimed to investigate the relationship between C677T and A1298C polymorphisms and osteoporosis in Turkish postmenopausal women. DNA samples were extracted from 200 volunteers. The PCR-RFLP technique was used to identify the MTHFR gene polymorphisms C677T and A1298C. The statistical significance of the analysis's results was assessed. C677T genotype and allele frequency distributions were not statistically different between postmenopausal osteoporosis and healthy control groups (p = 0.249, p = 0.754), while A1298C genotype and allele frequency distributions were found to be statistically significant (p = 0.002, p = 0.013). The results of our study showed that the A1298C polymorphism may be a genetic factor associated with osteoporosis in this specific population. However, the C677T polymorphism did not show a significant connection. To gain a more comprehensive understanding of the genetic basis of osteoporosis, future research with larger sample sizes and the consideration of additional genetic and environmental factors is essential. Additionally, it is crucial to account for ethnic disparities, gene-gene interactions, and gene-environment interplays. These insights can inform the development of personalized preventive and therapeutic strategies for individuals at risk of osteoporosis in diverse populations.
- 1 November 2024
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 44 (10) , 783-792
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Turkish postmenopausal women with osteoporosis
Osteoporosis is a common age-related skeletal disease, characterized by changes in the microarchitectural structure of bone tissue and decreased bone mass, especially affecting postmenopausal women. Genetic and environmental factors affecting bone metabolism play a role in the development of osteoporosis. Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in the conversion of homocysteine to methionine. Genetic variations in the MTHFR gene lead to impaired function or inactivation of this enzyme. A decrease in MTHFR enzyme activity and an increase in homocysteine levels affect bone metabolism. In this study, we aimed to investigate the relationship between C677T and A1298C polymorphisms and osteoporosis in Turkish postmenopausal women. DNA samples were extracted from 200 volunteers. The PCR-RFLP technique was used to identify the MTHFR gene polymorphisms C677T and A1298C. The statistical significance of the analysis's results was assessed. C677T genotype and allele frequency distributions were not statistically different between postmenopausal osteoporosis and healthy control groups (p = 0.249, p = 0.754), while A1298C genotype and allele frequency distributions were found to be statistically significant (p = 0.002, p = 0.013). The results of our study showed that the A1298C polymorphism may be a genetic factor associated with osteoporosis in this specific population. However, the C677T polymorphism did not show a significant connection. To gain a more comprehensive understanding of the genetic basis of osteoporosis, future research with larger sample sizes and the consideration of additional genetic and environmental factors is essential. Additionally, it is crucial to account for ethnic disparities, gene-gene interactions, and gene-environment interplays. These insights can inform the development of personalized preventive and therapeutic strategies for individuals at risk of osteoporosis in diverse populations.
- 3 March 2022
- Published by Springer Nature in Biological Trace Element Research
- Vol. 201 (2) , 603-610
Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures
Oxidative stress plays a role in the pathogenesis of bone loss, causing low bone mineral density (BMD) and associated osteoporotic fractures. In our study, we aimed to investigate the relationship of SOD1 50-bp insertion(Ins)/deletion(Del) polymorphism that is involved in oxidative stress metabolism, Cu and Zn element concentrations, and plasma viscosity level, with postmenopausal osteoporosis and related vertebral fractures. The study included 167 voluntary individuals. The 50-bp Ins/Del polymorphism of SOD1 was determined by allele-specific PCR. Plasma Cu and Zn levels were measured by atomic absorption spectrophotometry (AAS). The plasma viscosity was determined using the Harkness Capillary Viscometer device. In our study, the distribution of SOD1 promoter 50-bp Ins/Del polymorphism did not indicate a significant difference between the groups and in postmenopausal osteoporosis patients with and without fractures (p > 0.05). The Ins/Ins genotype was found to be common in individuals in both groups. The Cu and Zn levels of the study group were found to be between the normal reference values (p > 0.05). It was determined that plasma viscosity increased significantly in the group of osteoporotic patients and in patients with postmenopausal osteoporosis with fractures (p < 0.01). In addition, plasma viscosity was found to significantly increase in patients with Ins/Ins genotype and fractures (p < 0.01). Postmenopausal osteoporosis and associated vertebral fracture were found not to be directly related to SOD1 50-bp polymorphism and Cu and Zn element levels. Plasma viscosity levels were found to increase due to the increase in oxidative stress products. Further studies are needed to clarify the roles and relationships of SOD genes and trace elements in the development of postmenopausal osteoporosis and vertebral fracture.
- 3 March 2022
- Published by Springer Nature in Biological Trace Element Research
- Vol. 201 (2) , 603-610
Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures
Oxidative stress plays a role in the pathogenesis of bone loss, causing low bone mineral density (BMD) and associated osteoporotic fractures. In our study, we aimed to investigate the relationship of SOD1 50-bp insertion(Ins)/deletion(Del) polymorphism that is involved in oxidative stress metabolism, Cu and Zn element concentrations, and plasma viscosity level, with postmenopausal osteoporosis and related vertebral fractures. The study included 167 voluntary individuals. The 50-bp Ins/Del polymorphism of SOD1 was determined by allele-specific PCR. Plasma Cu and Zn levels were measured by atomic absorption spectrophotometry (AAS). The plasma viscosity was determined using the Harkness Capillary Viscometer device. In our study, the distribution of SOD1 promoter 50-bp Ins/Del polymorphism did not indicate a significant difference between the groups and in postmenopausal osteoporosis patients with and without fractures (p > 0.05). The Ins/Ins genotype was found to be common in individuals in both groups. The Cu and Zn levels of the study group were found to be between the normal reference values (p > 0.05). It was determined that plasma viscosity increased significantly in the group of osteoporotic patients and in patients with postmenopausal osteoporosis with fractures (p < 0.01). In addition, plasma viscosity was found to significantly increase in patients with Ins/Ins genotype and fractures (p < 0.01). Postmenopausal osteoporosis and associated vertebral fracture were found not to be directly related to SOD1 50-bp polymorphism and Cu and Zn element levels. Plasma viscosity levels were found to increase due to the increase in oxidative stress products. Further studies are needed to clarify the roles and relationships of SOD genes and trace elements in the development of postmenopausal osteoporosis and vertebral fracture.
- Open Access
Is there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study
In this study, the relationship between osteoporotic vertebral fractures and 9041 Guanine/Adenine and 3673 Guanine/Adenine polymorphisms related to the vitamin K epoxide reductase complex subunit-1 (VKORC1) gene in postmenopausal women with osteoporosis was investigated. DNA was isolated from blood samples collected from 150 women with postmenopausal osteoporosis. Genotyping of the two polymorphic regions (9041 Guanine/Adenine and 3673 Guanine/Adenine) in VKORC1 was performed using polymerase chain reaction-restriction fragment length polymorphism analysis. The presence of radiographic fractures among the 150 patients was ascertained by using the Genant method. At least one fracture was detected in 98 patients, and no fracture was observed in 52 patients on radiological images. We found no association between the 9041 Guanine/Adenine (p=0.283) and 3673 Guanine/Adenine (p=0.232) polymorphisms of the VKORC1 gene and the development of secondary postosteoporotic fractures in our study. There was no relationship between osteoporotic vertebral fracture and VKORC1 gene polymorphism in a postmenopausal Turkish population.
Open AccessIs there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study
In this study, the relationship between osteoporotic vertebral fractures and 9041 Guanine/Adenine and 3673 Guanine/Adenine polymorphisms related to the vitamin K epoxide reductase complex subunit-1 (VKORC1) gene in postmenopausal women with osteoporosis was investigated. DNA was isolated from blood samples collected from 150 women with postmenopausal osteoporosis. Genotyping of the two polymorphic regions (9041 Guanine/Adenine and 3673 Guanine/Adenine) in VKORC1 was performed using polymerase chain reaction-restriction fragment length polymorphism analysis. The presence of radiographic fractures among the 150 patients was ascertained by using the Genant method. At least one fracture was detected in 98 patients, and no fracture was observed in 52 patients on radiological images. We found no association between the 9041 Guanine/Adenine (p=0.283) and 3673 Guanine/Adenine (p=0.232) polymorphisms of the VKORC1 gene and the development of secondary postosteoporotic fractures in our study. There was no relationship between osteoporotic vertebral fracture and VKORC1 gene polymorphism in a postmenopausal Turkish population.